大禹生物
(871970)
| 流通市值：3.54亿 | | | 总市值：7.47亿 |
| 流通股本：5270.44万 | | | 总股本：1.11亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 115,156,370.54 | 69,247,737.67 | 29,231,472.9 | 156,983,059.01 |
| 营业收入 | 115,156,370.54 | 69,247,737.67 | 29,231,472.9 | 156,983,059.01 |
| 二、营业总成本 | 125,215,153.85 | 78,135,397.06 | 33,443,593.46 | 144,989,014.9 |
| 营业成本 | 85,514,270.98 | 51,242,622.76 | 21,916,375.99 | 88,219,050.52 |
| 税金及附加 | 810,219.72 | 776,269.21 | 145,651.94 | 1,677,589.37 |
| 销售费用 | 14,164,333.56 | 9,922,636.49 | 3,946,838.44 | 22,824,446.07 |
| 管理费用 | 15,709,693.19 | 10,306,505.65 | 4,636,128.14 | 21,510,803.22 |
| 研发费用 | 7,749,700.05 | 5,210,733.62 | 2,464,389.29 | 10,480,810.81 |
| 财务费用 | 1,266,936.35 | 676,629.33 | 334,209.66 | 276,314.91 |
| 其中:利息费用 | 1,438,493.05 | 843,769.46 | 479,947.23 | 488,162.25 |
| 其中:利息收入 | 186,844.52 | 174,651.04 | 148,989.98 | 227,543.82 |
| 资产处置收益 | 299,352.14 | 299,352.14 | - | - |
| 资产减值损失(新) | -94,315.73 | -149,663.5 | - | - |
| 信用减值损失(新) | -211,263.03 | -179,076.71 | 246,158.06 | -963,908.12 |
| 其他收益 | 3,955,979.67 | 2,572,829.65 | 969,079.63 | 4,550,595.8 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -6,109,030.26 | -6,344,217.81 | -2,996,882.87 | 15,580,731.79 |
| 加:营业外收入 | 100,294.58 | 75,003.81 | 26,581.95 | 4,354,281.75 |
| 减:营业外支出 | 503,540.76 | 3,540.76 | 88.86 | 16,402.11 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -6,512,276.44 | -6,272,754.76 | -2,970,389.78 | 19,918,611.43 |
| 减:所得税费用 | -217,931.02 | -205,417.96 | 36,576.53 | 1,771,421.86 |
| 六、净利润 | -6,294,345.42 | -6,067,336.8 | -3,006,966.31 | 18,147,189.57 |
| 持续经营净利润 | -6,294,345.42 | -6,067,336.8 | -3,006,966.31 | 18,147,189.57 |
| 归属于母公司股东的净利润 | -6,294,345.42 | -6,067,336.8 | -3,006,966.31 | 18,147,189.57 |
| (一)基本每股收益 | -0.06 | -0.05 | -0.05 | 0.37 |
| (二)稀释每股收益 | -0.06 | -0.05 | -0.05 | 0.37 |
| 九、综合收益总额 | -6,294,345.42 | -6,067,336.8 | -3,006,966.31 | 18,147,189.57 |
| 归属于母公司股东的综合收益总额 | -6,294,345.42 | -6,067,336.8 | -3,006,966.31 | 18,147,189.57 |
| 公告日期 | 2023-10-26 | 2023-08-28 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |